Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Jacob Harter

Diagnostic Radiology Santa Barbara, CA Medical Doctor

NPI 1063737914 CMS profile 7231202

2320 Bath St # 113, Santa Barbara, CA 93105

Open in the dashboard

General payments

$156

7 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$10,800 paid to institutions, not to them · program year 2025

Through program year 2024, Jacob Harter of Santa Barbara, CA is reported in the CMS Open Payments database as having received $156 across 7 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $10,800 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 52nd percentile of Diagnostic Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $21 1
2022 General $93 4
2021 General $20 1
2019 General $23 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jacob Harter
  • Diagnostic Radiology median
  • Middle half of Diagnostic Radiology
  • National median

In program year 2025, general payments to Jacob Harter were reported at $0. Among 8,325 Diagnostic Radiology profiles paid that year, the median was $112 and the middle half received between $32 and $349.

Show as a table
Year Jacob Harter Diagnostic Radiology median Middle half National median
2019 $23 $108 $29–$318 $163
2020 $0 $65 $21–$252 $114
2021 $20 $92 $24–$292 $132
2022 $93 $104 $29–$294 $149
2023 $0 $110 $29–$337 $160
2024 $21 $113 $30–$356 $164
2025 $0 $112 $32–$349 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Change Healthcare Technologies, LLC $60 2 payments
  2. Siemens Medical Solutions USA, Inc. $53 3 payments
  3. FUJIFILM Medical Systems USA, Inc. $23 1 payment
  4. Philips Electronics North America Corporation $21 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Food and Beverage $156 7 payments
Products named General payments · program years 2019–2024
  1. Change Healthcare Radiology Solutions $60 2 payments
  2. Synapse PACS (MI) $23 1 payment
  3. (1663) Clinical Education MRI $21 1 payment
  4. MAGNETOM Altea $20 1 payment
  5. Biograph Horizon-3R $17 1 payment
  6. MAGNETOM Sola $16 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 214 billing codes

Paid by Medicare

$517,386

Of which drugs: $3,454

Medicare patients

6,348

Average age 75

Services billed

23,360

3,955 women, 2,393 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 64%
Arthritis 63%
Osteoporosis 26%
Ischemic heart disease 23%
Depression 23%
Diabetes 22%
Chronic kidney disease 22%
Atrial fibrillation 18%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, gadoteridol, (prohance multipack), per ml A9576 Office 85 1,223 $1,413
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml Q9967 Office 151 11,868 $1,245
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml A9579 Office 30 540 $634
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 20 117 $92
Injection, methylprednisolone acetate, 1 mg J1010 Office 11 520 $53

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

7 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Diagnostic Radiology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record